Inno-Q-Nol
Natural health product licensed in Canada
- Other names
- Inno-Q-Nol CV10, Inno-Q-Nol CVH, Inno-Q-Nol CVI, Inno-Q-Nol Cardio & CVI, Inno-Q-Nol Cardio10, Inno-Q-Nol H.T.N, Inno-Q-Nol HP10
- Licence holder
- Innovite
- NPN or DIN-HM
- 80094575
- Status
- Inactive licence
- Licence date
- 23 September 2019
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Magnésium: up to 300 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ubiquinol Source : Ubiquinol | 50 milligramme | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 2,250 milligramme Potency : 90 % Oligomeric proanthocyanidins | 75 milligramme | Not calculated |
| Theobroma cacao Source : Theobroma cacao - Graine Potency : 12 % Theobromine | 125 milligramme | Not calculated |
| Magnésium Source : Citrate de magnésium | 150 milligramme | 300,000 µg |
| Magnésium Source : Oxyde de magnésium | 150 milligramme | 300,000 µg |
Non-medicinal ingredients
Saveur de cannelle, Eau purifiée, Saveur d'épices à la vanille, Cire d'abeille, Glycérine, Vanille, Huile de tournesol, Curcuma, Gélatine, Fécule d'arrow-root, Saveur de gingembre, Lécithine, Dioxyde de silicium colloïdal, Palmitate d'ascorbyle, Rocou, NA
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain and/or support cardiovascular health. Helps to reduce the frequency of migraine headaches and associated symptoms such as nausea and vomiting, when taken as a prophylactic/preventative. Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs. Source of/Provides antioxidants. Source of magnesium to support biological functions which play a key role in the maintenance of good health. Maintains and Supports good health. Helps in tissue formation. Helps to maintain (proper) muscle function. Helps maintain proper muscle function and tissue formation. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain heart muscle function. Provides an electrolyte for the maintenance of good health. Helps in energy metabolism. Helps to maintain normal electrolyte balance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80094575
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.